Sunrest Lifescience is all set to make its mark in the market with its upcoming Initial Public Offering (IPO). The IPO, valued at Rs 10.85...
Sunrest Lifescience is all set to make its mark in the market with its upcoming Initial Public Offering (IPO). The IPO, valued at Rs 10.85 crores, comprises an entirely fresh issue of 12.91 lakh shares. Investors have a limited window for subscription, as the IPO opens for applications on November 7, 2023, and closes on November 9, 2023. The allotment results are expected to be finalized by November 15, 2023.
Key Details:
- Issue Size: Rs 10.85 crores
- Fresh Issue: 12.91 lakh shares
- Issue Price: ₹84 per share
- Minimum Lot Size: 1600 Shares
- Minimum Investment (Retail): ₹134,400
- Minimum Investment (HNI): 2 lots (3,200 shares), amounting to ₹268,800
- Important Dates:
- Subscription Period: November 7, 2023, to November 9, 2023
- Allotment Date: November 15, 2023
- Listing Date: November 20, 2023 (Tentative, on NSE SME)
- Lead Managers and Registrars:
Mark Corporate Advisors Private Limited is the appointed Book Running Lead Manager for the Sunrest Lifescience IPO. Handling the registration process is Skyline Financial Services Private Ltd. Additionally, Svcm Securities has been designated as the market maker for the IPO.
Investment Insights:
With an issue price of ₹84 per share, Sunrest Lifescience IPO provides an opportunity for investors to enter the market at an attractive price point. The minimum lot size and investment requirements cater to both retail and high net worth investors, making this IPO accessible to a wide range of market participants.
GMP:
COMMENTS